Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom? - Wikidata - wikimedia - TriplyDB

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

http://www.wikidata.org/entity/Q36735465

about

Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study.Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study.Liver X Receptor Genes Variants Modulate ALS Phenotype.A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction.The Therapeutic Potential of Metformin in Neurodegenerative Diseases

P2860

Q38691517-42ABB628-86CB-4426-833C-5CA03355CDC7 Q38813077-BFFFA2E3-E4EC-4087-B1A5-390602BF414C Q47801166-70EE3AE2-010E-485F-8B36-55D40638150B Q48046253-7ACD5AC7-5633-43F8-95EC-64DFDC1EEE20 Q49633688-C1313B96-70E5-4A62-9AC5-5831050C4338 Q55368834-348BA363-8482-4ACB-BA0E-9ACB609CFFF2 Q57175337-5ADD6E40-A62B-4444-8C47-0E50C420373D

P2860

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

http://www.wikidata.org/entity/Q36735465

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@ast

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@en

type

label

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@ast

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@en

prefLabel

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@ast

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@en

P1433

Q36735465-0C279BF3-20CB-467E-9678-3F530E753D2D

P1476

Q36735465-18A546E3-8F6B-4EC4-83E0-73DD1EC66CF8

P2093

Q36735465-C2014118-60B4-43E1-9F55-1F1AB4954D29

Q36735465-E41AEBF4-44EB-4288-8098-EE008C9540BB

P2860

Q36735465-0137B3A4-A8A4-4AE4-95A4-96B868213AAA

Q36735465-0542D05C-7EEF-47C1-9A60-9B1DA3C67CF4

Q36735465-0DC6867C-79F0-43D6-B126-E71F067FCA05

Q36735465-0FE47A3E-8A2E-447B-9435-76E7746737A2

Q36735465-20828C85-D88C-48C0-959D-4FD73182A6F3

Q36735465-23AF005C-D46C-4D72-9E65-A2386DACE9C7

Q36735465-2AA67169-6E92-4D1C-B5BE-33AD3A00F120

Q36735465-2DBC9B27-301A-4E2B-9AF4-FB659BB69BEB

Q36735465-33499827-56EC-4A77-8985-46E225880CD8

Q36735465-38F165F7-C355-44C4-B37E-FE89452A39D2

P304

Q36735465-A88DBADD-4F8C-4772-82F5-3A07EC65E532

P31

Q36735465-F8AC93DA-A38A-4800-B25E-CB7C4133AB78

P356

Q36735465-5CD50383-D24A-48E7-9D08-7EB743A7B318

P478

Q36735465-2273D62C-A61C-402A-91D3-C6F0C4BF3683

P50

Q36735465-2807286F-8355-4C6E-9CE1-25B854A4A56C

P577

Q36735465-484B6A4E-BF8B-4D6A-958D-E14BF00D65AF

P698

Q36735465-AED918E1-D255-4735-A255-A65650669736

P921

Q36735465-B9D94359-5E9B-49C3-88E5-4D659DB8AEB4

P932

Q36735465-B6CFDE0D-82B3-48E2-BF70-B136F73F0DFF

P356

FNEUR.2016.00047

P1433

Frontiers in Neurology

P1476

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

@en

P2093

Ike S Okosun

http://www.w3.org/2001/XMLSchema#string

Sabrina K Hollinger

http://www.w3.org/2001/XMLSchema#string

P2860

The dynamics of somatic input processing in spinal motoneurons in vivo

Undergraduate Biocuration: Developing Tomorrow's Researchers While Mining Today's Data

Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes.

Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

Genetic factors in the early diagnosis of ALS.

Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.

Uric acid levels predict survival in men with amyotrophic lateral sclerosis.

Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Association between diabetes and amyotrophic lateral sclerosis in Sweden.

An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies

P304

47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNEUR.2016.00047

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Cassie S Mitchell

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27065942

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4810157

http://www.w3.org/2001/XMLSchema#string